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Teenagers and Young Adults with Cancer:
An Exploration of Factors Contributing to
Treatment Adherence
Elizabeth Carr, MSc, PG Dip, BA1 and
Leah Rosengarten, MSc, BSc2
Abstract
This systematic appraisal explores the literature surrounding treatment adherence in teenagers and young adults
(TYAs) with cancer, with the aim of identifying influential factors that could affect adherence rates. This area is par-
ticularly important due to the increased risk of relapse and death associated with nonadherent behavior. In addition,
TYAs are found to be the age group least likely to adhere to medical regimes. A comprehensive review of the literature
was conducted and seven studies met the inclusion criteria, the articles were then critiqued using a data extraction
form and eight themes were generated and discussed. This review highlights the complexities and difficulties in
measuring adherence, as well as the key factors affecting adherence, before identifying implications for practice. Good
communication and relationships are crucial between all parties involved in TYAs’ care including the patients, profession-
als, parents, and peers. A model of adherence was adapted on the basis of the result of the systematic review, other
literature pertaining to adherence in TYAs, and the clinical experience of the authors. Personal factors and external fac-
tors, along with treatment factors and interactions with the system all have an effect on the patient’s response or ability
to adhere. It is apparent that there is a need for more high-quality qualitative and quantitative research in this area, with
an emphasis on finding interventions that directly improve adherence specific to this age group.
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Introduction and Background
Cancer is the leading cause of nonaccidental death in ado-
lescents, with research significantly suggesting that
between 50% and 63% of patients do not adhere to their
treatment (Kennard et al., 2004; Kondryn et al., 2011;
Teenage Cancer Trust, 2014). Whilst even the most
adherent patient can relapse or not survive depending
on the type and severity of cancer they have, being adher-
ent gives the best possible chance of success, especially
concerning the use of chemotherapies and antibiotics
(Kondryn et al., 2009; Rohan et al., 2013).
The World Health Organisation (2003, p. 13) defines
adherence as “the degree to which a person’s behaviour
corresponds with the agreed recommendations from
their health care provider.” There are overlapping defini-
tions and interchangeable use of terms such as “adher-
ence,” “compliance,” and “concordance” being used,
but results reveal “adherence” as the most commonly
used term in recent and current literature. The age range
of patients focussed on within this systematic appraisal
is between 13 and 24 years old and will consider “teen-
agers and young adults” (TYAs), as this is found to be
the age group least likely to adhere to medical regimes
(Abrams et al., 2007; Hawwa et al., 2009). Although
this article aims to explore all aspects of nonadherence
(NA), current research predominantly measures adher-
ence in terms of medication taking.
There are a variety of different types of NA in medica-
tion taking; one is a clear refusal to take the prescribed
medication (Nevins, 2002), where another may come
from a patient accidentally missing a dose, realizing that
there is no immediate medical consequence and then
adopting a more casual attitude to medication taking
(Abrams et al., 2007; Buchanan et al., 2014; Nevins,
2002). If there is no immediate effect or obvious repercus-
sions to missing medication, this may cause the TYAs to
doubt medical advice about the damaging effects of
missing medication (Buchanan et al., 2014) and may
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even give the teenager a sense of invincibility and invul-
nerability (Dobbels et al., 2005). A further type of NA
may occur if TYAs decide that the overall consequences
of taking their medication, for example the medication
being too strong or having too many side effects, are
simply unacceptable and either omit or reduce the
intake of the drug (Nevins, 2002; Windebank &
Spinetta, 2008). It is noted that NA is not always inten-
tional, but may occur due to confusion over dosage or
who is responsible for the medication administration
(Abrams et al., 2007). It is also important to remember
that NA is not just about medication taking, it can also
be in relation to not reporting illnesses or episodes
such as temperatures that may affect treatment or need
for treatment (Kondryn et al., 2009).
Previous research has highlighted that the adherence of
TYAs with cancer is an area requiring further develop-
ment and exploration (Enskar & Von Essen, 2007;
Kondryn et al., 2011). It is established that there are
links with nonadherent TYAs and higher rates of depres-
sion, lower self-esteem, and reports of poorer parent–
child relationships (Kennard et al., 2004). Numerous
studies have found a correlation between family relation-
ships and treatment adherence, suggesting that the role of
the parent has a significant impact on the patient’s adher-
ence (Kennard et al., 2004; Kondryn et al., 2011;
Windebank & Spinetta, 2008). Additionally, due to an
increased availability of oral medications for cancer treat-
ment, patients are now expected to take more responsibil-
ity for their medical regimes at home (Abrams et al.,
2007; Kennard et al., 2004).
Methods
The Wiley Online Library, Proquest, Cochrane
Collaboration, and Northumbria University’s NORA
database were searched. Due to the overlapping defini-
tions and the interchangeable use of terms such as adher-
ence, compliance, and concordance being used within the
literature, all terms were searched to represent different
attributes of this complex concept (Table 1).
Table 2 displays the inclusion and exclusion criteria
applied to the search. Due to the introduction of the
National Institute for Health and Clinical Excellence
report “Children’s and Young People’s Improving
Outcome’s Guidance” in 2005 and a change in the way
and where TYAs received their treatment, journals from
2005 onwards only, have been included. To ensure the
quality of data, any non-peer-reviewed research journals
were excluded. Research that did not focus primarily on
adherence was excluded to reduce the number of con-
founding variables. As the reasons for NA or abandon-
ment of treatment differ largely in developing countries,
due to financial difficulties, transportation issues, and dif-
fering beliefs and cultures (Sitaresmi et al., 2010), only
studies conducted within developed countries have been
included.
The search resulted in 147 articles, the inclusion/exclu-
sion criteria were applied, narrowing the search down to
35 articles. From this abstracts were read and the dupli-
cate and irrelevant articles were removed, this left a
remaining five articles. Hand searching of reference lists
from relevant journal articles was also carried out and a
further two articles were identified. This resulted in a
total of seven articles being selected for this systematic
appraisal (Table 3). The databases were searched regu-
larly to find any new research published but no new arti-
cles were found.
To establish themes from the literature, the six-phase
guide to conducting a thematic analysis, as outlined by
Braun and Clarke (2006), was used. Researchers initially
independently familiarized themselves with the seven
chosen articles and generated initial codes. These codes
were then jointly reviewed by both researchers and dis-
cussed to identify interrelating themes. Only minor dis-
crepancies were apparent during coding which mostly











Table 2. Table of Inclusion/Exclusion Criteria.
Inclusion Exclusion
Peer-reviewed journals only Non-peer-reviewed
Qualitative and quantitative
studies
Systematic review on the
subject area
Articles written from 2005
onwards
Articles dated from before
2005
Studies in the English language Non-oncological papers
Articles with the primary
focus being adherence in
TYAs with cancer
Articles where the primary
focus was not adherence
Articles written in developed
countries
Articles written in developing
countries
Focussed on age range 13–24
year olds




Note. TYAs= teenagers and young adults.
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related to precise naming of the theme; these were dis-
cussed and names reflective of the wider literature were
decided upon.
Results
All studies found similar results despite the difference in
countries and methods chosen. Eight themes were identi-
fied during the data analysis, these were difficulties in
measuring adherence, healthcare professionals’ role in
addressing adherence, interventions to improve adher-
ence, the role of the parents, the transition to maintenance,
more information for TYAs, risk-taking, and a desire for
“normal life.” Table 4 identifies how each theme arose
from each of the seven articles.
Difficulties in Measuring Adherence
The first theme identified from the thematic analysis was
difficulties in measuring adherence, which was high-
lighted in all seven studies. The studies used a variety
of methods to address and measure adherence including
blood tests, electronic pillbox monitoring, and self-
reporting both during treatment and retrospectively.
Studies 2, 3, 4, 6, and 7 directly measured adherence
through a quantitative design method. Studies 2, 6, and
7 used a measure of 95% or above as being an optimum
adherence rate, Bhatia et al. (2012) also recommend this
percentage, with this in mind none of the studies mea-
sured adherence at above 95% adherence “The mean
adherence rate was 86.2%. Adherence rates declined
over the 1 month follow to 83.3%” (Study 6, p. 1).
Studies 2, 3, and 6 aimed to directly measure adherence
using objective and subjective methods of measurement
and reporting. As there is currently no unified approach,
assessing adherence is difficult, which has been highlighted
as a commonly discussed limitation (Studies 3, 6, and 7). It
was identified in Bhatia et al.’s (2012) study that if adherence
falls below 95%, the rate of relapse increased. Studies 2, 6,
and 7 used this benchmark of 95% for the TYAs to be con-
sidered adherent. However, determining how to measure
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parents, and professionals’ perspectives on what adher-
ence is, may also differ (Studies 3, 6, and 7).
Studies 2, 4, and 7 used blood tests to record levels of
adherence, whilst Study 2 also used subjective reports
of adherence. The results from Study 4 showed that
TYAs are significantly more likely to show nonadherent
in both self-reports and metabolites than younger chil-
dren “Demographic factors examined for possible asso-
ciation with non-adherence were gender and age…
higher age was significantly associated with non-
adherence” (Study 2, p. 1110). In contrast to this
whilst Studies 6 and 7 found adherence was below the
optimum level, they reported no difference in demo-
graphic characteristics such as age, ethnicity, race, and
family structure.
Although, it is argued that using objective measure-
ments such as blood tests and electronic monitoring, for
example pillboxes, is a more reliable measurement than
self-reporting, even these methods are subject to criticism.
Patient manipulation and pharmacokinetic variability, for
example drug absorption, distribution, and metabolism
must be taken into consideration (Study 6). Studies 2
and 7, therefore, sought to combine these two measures
to combine the benefit of both methods of monitoring.
Study 3 used a self-reporting questionnaire on adher-
ence; they found TYAs did not adhere to up to 38% of
low-risk treatment. Twenty-five percent had not reported
pyrexia and diarrhea and 33% had considered stopping
treatment. Studies 2 and 3 argue that to address NA, it
must be dealt with from the beginning of treatment and
continually reassessed; however, research suggests that
often adherence is addressed retrospectively (Studies 1,
3, and 4). There are a lot of reservations in using self-
reports of adherence due to their subjective nature often
resulting in misrepresentation and overestimation of
adherence (Study 3). Despite this self-reporting was
found to be the most commonly used tool in measuring
adherence, due to it being easy to do, inexpensive, and
easily utilized by all members of the healthcare team
(Studies 1, 3, and 4). The mixed-method approach used
in Study 2 found a correlation between self-reporting
and the blood level results, highlighting that when
asked to report the TYAs reported truthfully about adher-
ence. It was also found that TYAs who reported NA early
on were likely to continue with adherence issues through-
out treatment.
Healthcare Professional’s role in Addressing
Adherence
The role of the healthcare professional in recognizing and
addressing NA was apparent within all of the articles.
“Findings of this investigation clearly illustrate the need
for medical providers to repeatedly assess adherence”
(Study 2, p. 234). This was also a recommendation in
Study 3 where it was interestingly found that as the
number of visits to the healthcare professional increased
patients became more open in reporting NA. This may
indicate patients need some time to report NA, thus sup-
porting the need to continually monitor. TYAs should be
asked whether they are taking their medications as pre-
scribed and whether the regimen is causing them distress
or side effects, then address any issues found. The results
from the studies found this communication optimum in
achieving adherence (Studies 1, 4, 5, and 7). This commu-
nication must be done in an open and nonstigmatized
way, so that good patient–professional relationships are
maintained. This building of trust and mutual information
sharing constitutes what can be argued as being one of the
most important intervention strategies that we can apply
to reduce TYAs NA. It is important to remember that
the responsibility does not solely lie with the medical
team, as the nursing staff and other health professionals
also have a responsibility in addressing NA.
Interventions to Improve Adherence
Interventions aimed at promoting adherent behavior was
also a theme arising from all of the articles. This is sup-
ported in the following quote “it was recognised that
because of their development stage and shifting levels
Table 4. Themes.
Themes Study 1 Study 2 Study 3 Study 4 Study 5 Study 6 Study 7
Difficulties in measuring adherence ✓ ✓ ✓ ✓ ✓ ✓ ✓
Healthcare professional’s role in addressing adherence ✓ ✓ ✓ ✓ ✓ ✓ ✓
Interventions to improve adherence ✓ ✓ ✓ ✓ ✓ ✓ ✓
Role of the parents ✓ ✓ ✓ ✓ ✓ ✓
Transition to maintenance ✓ ✓ ✓ ✓ ✓
More information for TYAs ✓ ✓ ✓ ✓
Risk–taking ✓ ✓ ✓
Desire for “normal life” ✓ ✓ ✓
Note. TYAs= teenagers and young adults.
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of responsibility between adolescents with cancer
(AWC), their parents and healthcare team, assisting
AWC in developing these skills is vital” (Study 5,
p. 282). The suggested interventions based on the findings
of the studies ranged from monitoring adherence to com-
munication with healthcare professionals and other
TYAs. It is consistently argued that early intervention is
crucial in addressing adherence. However, due to the
limited methodological approaches and small sample
sizes used within the articles, there is a clear need for
both focussed qualitative and quantitative research to be
conducted to substantiate these findings further.
The first key recommendation is that simply monitor-
ing adherence can increase adherence (Studies 1–3, 6,
and 7). As the patients/parents within Studies 2, 3, 6,
and 7 were aware that adherence was being monitored
subsequently findings may have been influenced by
patient and family expectations and reactivity. Study 6
argues that if TYAs are aware that adherence is being
monitored either objectively or subjectively this could
increase adherence. Yet despite this, the studies still
found incidents of NA. Discussing the importance of
adherence may be beneficial because it may spur those
with poor adherence to improve and may encourage
those with good adherence to continue (Studies 1 and 4).
A positive and effective communication is therefore an
important intervention in addressing adherence.
Communication with peers was also highlighted as an
intervention in Studies 1, 4, and 5. Study 5 argues that
establishing a connection with other TYAs with cancer
is critical in supporting adolescent development and self-
management skills. Therefore, this highlights that peer
interaction may actually improve adherence rates.
Role of the Parents
The role of the parents in TYAs NA was highlighted
within six of the seven articles, with research suggesting
that NA is highest when TYAs are responsible for their
own medication (Studies 1 and 4). “Participants identified
parental support as a key factor in their adherence to
maintenance therapy” (Study 1, p. 147). It was high-
lighted as a main finding in four articles, thus showing
strength in the importance of their involvement and the
parent/child relationship.
Study 4 highlighted a correlation between family rela-
tionships and adherence, suggesting that the role of the
parent significantly impacts on the patient’s willingness
or ability to adhere. Study 1 identified parental support
as a key factor in achieving adherence, this was either
through administering the medication or through motivat-
ing the TYAs to self-administer. Three out of four partic-
ipants in this study who reported parental involvement
were deemed to have “optimal” adherence. It was also
found that mothers played a more significant role.
Study 3 found similar results stating that TYAs were
the worst compliers; this could be due to their managing
their own medication administration. Even if the TYAs
self-administers their medication, the parent still has a
role in monitoring/encouraging this (Studies 1 and 3).
It is important to remember that some TYAs have no
choice in solely managing their treatment and some
TYAs may be able to solely manage. However, results
from Study 1 demonstrated that parental involvement/
encouragement positively affected adherence.
Transition to Maintenance
Studies 1, 2, 3, 6, and 7 focussed on acute lymphoblastic
leukemia (ALL), the treatment for this is completed in
several phases, which led to the 5th theme; transition to
maintenance.
Once initial phases of treatment for ALL have been
completed, usually lasting around 6 months the TYAs
then starts the maintenance phase (Study 2). The mainte-
nance phase is a prolonged course of oral chemotherapy
6-mercaptopurine (6MP) and is essential in achieving a
long-term, disease-free survival (Study 3). However, it
was found that this is when NA is at its highest. Study
1 found that many of their participants identified the tran-
sition to maintenance as a turning point in their treatment.
Some viewed this as a positive turning point, expressing
relief. However, some TYAs expressed difficulty in
accepting that despite being leukemia-free they must con-
tinue this drug therapy. This could be due to most TYAs
being asymptomatic during this phase (Studies 3 and 6).
The length of the maintenance phase may also be a
factor in relation to NA, the TYAs may become noncha-
lant about taking medication (Study 1). Study 6 found
that adherence deteriorates over the course of treatment
lasting ∼2 years.
Studies suggest that during this phase of treatment,
more information should be given to the TYAs about
the importance of adherence (Studies 3, 6, and 7).
More Information for TYAs
With the above theme in mind, it was recommended in
Studies 1, 2, and 7 that more information be given to
TYAs regarding the maintenance phase. This information
should remind TYAs that although they may be asymp-
tomatic, the rate of relapse increases if adherence is not
optimal (Studies 1 and 2). This recommendation for
more information is not limited to only TYAs on mainte-
nance regimes in ALL treatment, but can also be useful
for all TYAs undergoing cancer treatment
Study 1 found that clinicians unknowingly reinforced
NA, by giving positive feedback regarding their remission
status. The participants drew a casual correlation between
not taking their medication and continuing to get better.
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This could be due to an inability to conceptualize long-
term consequences for NA (Study 1). Study 6 argues
NA is found to increase the rate of relapse both during
and post-treatment. Health professionals and parents
must be aware of this and continue to encourage adher-
ence even when patients are asymptomatic (Studies 1
and 6). However, a significant point to remember is that
even the most adherent TYAs may relapse but optimum
adherence gives the TYAs the best possible chance at
long-term survival.
Study 5 focussed on improving TYAs self-
management skills, these skills are found to increase
adherence. The study highlighted the TYAs need for
information surrounding immediate and long-term
impacts, body image, and lifestyle choices. With this in
mind, they propose that all TYAs with cancer are given
the necessary information and education they require
throughout treatment.
Risk-Taking
Risk-taking was a theme that arose from Studies 1, 4, and
5. Though precisely what constitutes risk can be difficult
to define, when relating this to TYAs NA, there is a life-
endangering risk associated with not adhering to medica-
tion regimes.
Study 1 found what they referred to as “egocentricity”
and “concrete thinking” had an effect on adherence.
These led to risk-taking behavior, which was also men-
tioned in Studies 4 and 5. Whilst the studies suggest
that risk-taking is a normal and adaptive part of adoles-
cence, however, this type of risk-taking is potentially
life-endangering.
Being asymptomatic was a recurring factor in display-
ing risk-taking behavior, participants in Study 1 reported
that they were getting better regardless of whether they
took their prescribed medication. Whilst the repercussions
of withholding a few doses are not immediate the psycho-
logical effects are far greater. As the TYAs may then start
to doubt what their doctors, other medical professionals,
and parents are telling them about the damaging effects
of missing medication (Study 1).
A Desire for “Normal Life”
A desire to feel “normal” was highlighted within Studies
1, 4, and 5. These feelings of wanting to remain “normal”
could be in relation to acknowledging their illness, family
life, peer relations, and social activities (Studies 1 and 4).
Study 1 reports that participants, once able to return to
what they deemed “normal” activities, continued to take
medication, which acted as a constant reminder that
they remained different. Although this relationship is
not mutually exclusive, the results of this study identified
the need for normalcy in nearly all aspects of the patients’
lives.
Studies 1 and 5 also place focus on improving quality
of life (QOL) for TYAs with cancer. Study 5 aims to
improve self-management skills in areas such as manag-
ing symptoms, lifestyle, treatment, physical and psycho-
logical consequences of living with cancer to improve
QOL, along with adherence rates and outcome.
Poor QOL could be a result of numerous factors
including dealing with a potentially life-threatening
illness, changes in physical appearance, and emotional
well-being. TYAs with a cancer diagnosis may already
feel differently from their peers. The added changes in
physical appearance were found to have various conse-
quences on the TYAs emotional well-being, such as
aggression, depression, low self-esteem, and feelings of
emotional frustration towards their dependency on treat-
ment (Studies 1 and 2). Study 1 suggests that these
factors are closely linked to adherence rates. The self-
management strategies in Study 5 aimed at improving
these factors include increasing knowledge base, learning
opportunities, and establishing meaningful social support
networks (Study 5).
However, it is important to remember the relationship
between QOL and adherence although linked is not causal
in nature, improved QOL does not automatically improve
adherence and vice versa. This is certainly an area for
further research.
Discussion
Currently, there is not one specific measurement of med-
ication adherence for TYAs, as there are inconsistencies
in the literature surrounding the best methods of measure-
ment. The difficulties around measuring adherence come
from divided opinion on whether objective or subjective
measurements provide the best results.
Some studies have conducted blood tests to measure
adherence which is often done to measure 6MP levels
within the bloodstream (Hawwa et al., 2009; Pai et al.,
2008; Rohan et al., 2017; Traore et al., 2006).
Measuring adherence in this way can provide information
that is less vulnerable to self-reporting bias (Pai et al.,
2008). If TYAs have low levels of the 6MP metabolites,
it would suggest that the TYAs are not receiving their full
medication dosages, for example being nonadherent.
However, pharmacokinetic variability must be considered
in relation to drug absorption, distribution, and metabo-
lism (Ruddy et al., 2009).
Another way of measuring adherence is through elec-
tronic monitoring, this approach consists of a system
whereby the cap on a pill bottle electronically records
the date and time the cap of the pill bottle is removed
(Rohan et al., 2013; Ruddy et al., 2009). Yet this approach
can be subject to patient manipulation as the pill may be
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discarded or not taken at the exact time the bottle is
opened (Rohan et al., 2013, 2017; Ruddy et al., 2009).
It has been demonstrated that combining blood level mon-
itoring with electronic monitoring can provide more accu-
rate information as to whether low 6MP metabolite levels
are due to NA or pharmacokinetic variability (Rohan
et al., 2017).
Subjective reports of adherence have also been a focus
for research (Kondryn et al., 2009; Pai et al., 2008). Often
subjective reports identifying nonadherent behavior are
carried out retrospectively. However, Kondryn et al.
(2009) and Pai et al. (2008) argue that to address NA, it
must be dealt with from the beginning of treatment and
continually reassessed. There is a lot of reservations in
using self-reports of adherence due to the subjective
nature often resulting in misrepresentation and overesti-
mation of adherence (Hawwa et al., 2009). Using self-
reports is the most widely utilized as it is inexpensive,
easy to use, and can be carried out by any member of
the healthcare team (Hawwa et al., 2009; Malbasa et al.,
2007).
Rohan et al. (2013) and Ruddy et al. (2009) argue that
if TYAs are aware that adherence is being monitored
either objectively or subjectively this could increase
adherence, known as “the Hawthorn effect” (Ruddy
et al., 2009). This would perhaps indicate that the
method of measuring adherence may never be fully reflec-
tive of actual NA. However, this may also support the use
of monitoring of NA in TYAs to improve adherence.
The “healthcare professional’s role in addressing
adherence” was a theme identified. Numerous studies
have highlighted the importance of their role in address-
ing adherence (Kondryn et al., 2009; Malbasa et al.,
2007; Rohan et al., 2017; Ruddy et al., 2009). The role
of healthcare professionals in ensuring good relationships
and a positive interaction with the healthcare system is
complex, with healthcare professionals being required to
build trust and have open communication with TYAs,
whilst also monitoring for NA and providing education.
One key role of the healthcare professional is to
monitor NA by asking TYAs whether they are taking
their medications as prescribed and whether their
regime is causing them distress or problems with side
effects (Ruddy et al., 2009; Windebank & Spinetta,
2008) However, this communication must be carried out
in an open and nonstigmatizing way, so that good
patient–professional relationships are maintained
(Windebank & Spinetta, 2008).
Ruddy et al. (2009) and Stinson et al. (2012) argue that
discussing the importance of adherence has also been
found to be beneficial, as it may spur those with poor
adherence to improve and may encourage those with
good adherence to continue. Along with this, they
stated that TYAs must be educated in their treatment
regimes, to fully understand what they are taking and
why (Coyne et al., 2019; Ruddy et al., 2009; Stinson
et al., 2012). The National Service Framework for
Children (Department of Health, 2004) advocates this
shared decision-making between parents or carers, chil-
dren or young people, and professionals. This is achieved
by involving TYAs in discussions of the risks and benefits
of treatment and taking into account their values and
beliefs and the effects the proposed treatment could
have on their daily living. This increased collaboration
has also been recognized within government initiatives
such as “Transforming Participation in Health and
Care” (NHS, 2013) and “Patient and Public
Involvement in the NHS” (Great Britain. Parliament.
House of Common, 2007).
Whilst the term “adherence” is most commonly used
within the literature, the term “concordance” is becoming
a more popular concept. This is where the prescriber and
the patient come to an agreement about their treatment
regime (Horne et al., 2005). The active inclusion of the
TYAs in this dialogue regarding treatment helps set an
atmosphere of compliance. It can improve the profes-
sional–patient relationship from compliance (doctor’s
recommendations) through to adherence (sticking to the
plan) to concordance (harmonizing) (Coyne et al., 2019;
Horne et al., 2005; Windebank & Spinetta, 2008).
Consideration of the “Hawthorn effect” (Rohan et al.,
2013; Ruddy et al., 2009) again has a role to play here as
healthcare systems that place an importance on monitor-
ing adherence, could see the benefits of improved adher-
ence. However, this action must be offset against the risk
that monitoring adherence could endanger the quality of
the trusting relationships that healthcare professionals
seek to build with TYAs.
The role of the parents was another theme highlighted
in the appraisal. Numerous studies have found a correla-
tion between family relationships and compliance,
suggesting that the role of the parent significantly
impacts the patient’s adherence (Kennard et al., 2004;
Kondryn et al., 2011; Windebank & Spinetta, 2008). It
is found that inconsistent styles of parenting and lack of
ability to discipline reinforce unwanted behavior such as
NA (Kalb & Loeber, 2003). There are numerous factors
that influence parenting style, which in turn impact rates
of adherence, for example when anxious parents restrict
their TYAs behavior unnecessarily, it was found to nega-
tively influence adherence (Kennard et al., 2004).
Berquist et al. (2008) found that adolescents from a
single-parent family are at a higher risk of NA, this
could be down to a variety of reasons. It could be
linked to socio-economic status, as single-parent families
on average have a lower income, due to an inability to
work many hours or unemployment due to the needs of
having an ill child (Brown et al., 2008; Lubkin &
Larsen, 2013; Windebank & Spinetta, 2008). Or having
to work many hours to independently support the
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family and as a result not being able to attend appoint-
ments or have the time to manage or monitor medication
intake. Studies have found that patients whose parents
accompanied them to appointments were significantly
more likely to adhere to medical treatments (Griffin &
Elkin, 2001). This could affect the adolescent as Griffin
and Elkin (2001) reported that feelings of resentment
and hostility from the parents often affected adherence
and the parent–child relationship.
An important developmental task during adolescence
is forming an identity separate from your parents, it is
also a time for growing independence (Buchanan et al.,
2014; Grinyer, 2009) yet it was found that one of the
most common reasons teenagers miss medication is that
they simply forget. Research suggests that despite a
growth in maturity, teenagers lack the ability to imagine
abstract concepts, for example the future consequences
of present actions (Buchanan et al., 2014; Windebank &
Spinetta, 2008).
Whilst the findings from the appraisal identified transi-
tion to maintenance as a key time for NA, Grinyer (2009)
states that one of the most common reasons for not taking
or reducing medication intake is down to the side effects.
This is an important consideration in TYAs NA, as the
principles of medical ethics guide that the benefits of a
medication should outweigh the harm, and this should
allow for consideration of the individual’s perspective.
More information for TYAs needs to be given with
regard to all stages of treatment both in the initial stages
and in the maintenance phase to better prepare TYAs
for their cancer journey and issues that may arise. This
information is also important for healthcare professionals
to have a better understanding of how the TYAs may be
feeling and why they may be NA.
Some of the most commonly reported side effects of
cancer treatment are hair loss, weight gain or loss, muco-
sitis (inflammation and ulceration of the mucus mem-
branes), pain, and lethargy (Abrams et al., 2007;
Grinyer, 2009; Miller et al., 2011). Whilst undergoing
treatment, TYAs frequently express concerns about
appearance and body image. Whilst weight gain and
acne are common amongst teenagers regardless of
health (NHS, 2012), the effects of this are likely to be
accelerated and intensified when on medication such as
steroids (Anderzen-Carlsson et al., 2012). One study
found that by the end of treatment for ALL 23% of the
patients were obese, compared with only 14% on diagno-
sis (Withycombe et al., 2009). TYAs may reduce or omit
their medication in an attempt to avoid gaining extra/
unwanted weight. Grinyer (2009, p. 204) found that
weight gain during treatment was described as “distress-
ing and demoralizing.” As a result of this the TYAs lost
confidence and self-esteem, Kennard et al. (2004)
suggest that there are close links between higher self-
esteem and higher adherence rates.
As nausea and sickness are some of the most com-
monly reported side effects of chemotherapy, weight
loss can also affect the TYAs making them feel self-
conscious about their appearance. Again, they may, there-
fore, decide to omit their medication (Windebank &
Spinetta, 2008). Whilst there is a vast range of antiemetic
therapies available patients may refuse or forget to take
them, they may also feel that they do not work so omit
to take them (Horne et al., 2005; Windebank &
Spinetta, 2008).
Grinyer (2009) reported in her study that hair loss was
the biggest cause of anxiety in TYAs with cancer. Hair
can be lost due to chemotherapy or in preparation for
surgery, for example for a brain tumor. Patients are
likely to find this distressing (Hedstrom et al., 2004;
Gibson & Soanes, 2008). Patients in this study reported
wanting to delay treatment to have their hair for longer.
Anderzen-Carlsson et al. (2012) found similar results,
stating that the girls in their study all reported difficulty
in accepting hair loss, and many faced denial about it hap-
pening to them.
TYAs may also have scars from tumor resections or
from having central venous access. Surprisingly, little
research has been done in relation to scars and their
impact on QOL (Brown et al., 2008); however, research
does suggest that scars do have an impact on self-
consciousness and anxiety (Abrams et al., 2007; Tebble
et al., 2005). Scars can have an impact on communication
skills, relationships, and leisure activities (Brown et al.,
2008). Along with an increasingly peer focussed lifestyle
and the natural changes in the body and body conscious-
ness during adolescents, it could be argued that the addi-
tion of scarring can be detrimental to a patient’s mental
health (Michaud et al., 2004; Abrams et al., 2007).
According to De Castro and Moreno-Jimenez (2008),
body consciousness and issues around physical appear-
ance could also be due to TYAs having to show their
bodies to medical professionals on a regular basis, these
experiences are reported as shaming and compromising
the patient’s privacy and negativity affecting their rela-
tionship with their body. In response to this TYAs may
downplay or chose not to disclose any issues/symptoms
to the medical professional (Smith et al., 2007). It could
be argued that this is also a type of NA, as it could
result in a mismanagement of symptoms or even relapse
(Smith et al., 2007; Windebank & Spinetta, 2008).
Studies suggest that hair loss, weight changes, the
presence of a central venous catheter or a nasogastric
tube, and scars from surgery, are the most disturbing
physical changes, and can be devastating to an adoles-
cent’s self-image (Larouche & Chin-Peuckert, 2006;
Lee et al., 2012). TYAs with a cancer diagnosis may
already feel different from their peers, these added
changes in physical appearance may have various conse-
quences such as aggression, depression, low self-esteem,
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and feelings of emotional frustration towards their
dependency on treatment (Abrams et al., 2007; Grinyer,
2009; Stinson et al., 2012).
To mitigate the possible damage of NA, the role of the
healthcare professional is again paramount. It is argued
that discussing the importance of adherence has also
been found to be beneficial, as it may spur those with
poor adherence to improve and may encourage those
with good adherence to continue. Through educating
TYAs in their treatment regimes, TYAs will be supported
to fully understand why the benefits of their treatment out-
weigh the perceived harm (Coyne et al., 2019; Ruddy
et al., 2009; Stinson et al., 2012).
Anxiety, low self-esteem, and social withdrawal are all
psychological factors associated with cancer, and they
may influence the adolescent’s ability to understand the
consequences of NA (Buchanan et al., 2014; Stinson
et al., 2012). Strong links have been found between low
self-esteem and low adherence rates, with studies suggest-
ing the two are closely correlated (Abrams et al., 2007;
Kennard et al., 2004).
Interestingly, scientific studies have found that embar-
rassment and self-consciousness in teenagers stimulate
the same part of the brain as actual physical pain
(Phillips, 2007). To prevent this it is possible that teen-
agers could omit to take their medication in an attempt
to feel “normal” or “ordinary,” an example of this could
be that they do not take their medication at the correct
time so they do not have to interrupt social activities
(Grinyer, 2009; Stinson et al., 2012). It is important to
understand the challenges faced by adolescents to incor-
porate this complex and strict routine into an increasingly
peer focussed lifestyle (Zelikovsky et al., 2008). Feinstein
et al. (2005) found that although teenagers were aware
they remained different from their peers, they made a con-
tinual effort to lead a “normal” life. These issues can then
bring on anxiety and sometimes denial. Often denial can
then serve as a defense mechanism against the anxiety and
depression associated with their conditions (Feinstein
et al., 2005).
Whilst it can be argued that many TYAs may attempt
to lead a “normal” life, Griffin and Elkin (2001) found
problems in social adjustment and withdrawal from
their social groups. Numerous studies found that TYAs
feel withdrawn from their peers during treatment
(Grinyer, 2009; Sayer et al., 2007). This could be due to
feelings of self-consciousness about appearance, or feel-
ings of isolation and exclusion from social activities due
to long periods spent in hospital and low school atten-
dance (Griffin & Elkin, 2001; Michaud et al., 2004; Pini
et al., 2013). This again highlights the importance of
Teenage Cancer Trust (TCT) units and peer support.
Griffin and Elkin (2001), in their review of the current
literature surrounding organ transplantation, found
reports of problems in TYAs social adjustment and
withdrawal from their social group. This was found
to be much higher than the normative control sample
of “well” children. Grinyer (2009) and Kennard et al.
(2004) also found similar reports of social withdrawal.
As adolescence is a time of psychosocial development,
peer group acceptance is fundamental in the transition
to adulthood. This lack of peer group support may
prevent the TYAs from having a sense of belonging
(Smith et al., 2007). Numerous studies have found
that TYAs feel withdrawn from their peers during
treatment (Grinyer, 2009; Sayer et al., 2007). This
could be due to feelings of self-consciousness about
appearance, or feelings of isolation and exclusion
from social activities due to long periods spent in hos-
pital, poor educational attainment, and low school
attendance (Griffin & Elkin, 2001; Michaud et al., 2004;
Pini et al., 2013).
Griffin and Elkin (2001) and Michaud et al. (2004)
found that a TYA speaking to a peer who has had
issues with adherence and becomes critically ill because
of this may help the adolescent realize the life-threatening
danger they are putting themselves in. There is little liter-
ature to support whether an intervention such as this
would have a long-term effect on TYAs NA, although
public health literature would argue that more factors
are required for behavior change. For example, Kok
et al. (2014) suggest that an individual requires a belief
that their behavior may be a risk, a model for the
desired behavior (such as the peer identified above), and
a belief in the change.
Lastly, development theorists portray adolescence as a
time for growth in maturity, the development of identity,
new body image, and sexuality (Epleman, 2013;
Lightfoot et al., 2013). Many studies suggest that risk-
taking is a normal and adaptive part of adolescence
(Kennard et al., 2004; Kondryn et al., 2011; Trevino
et al., 2013). Whilst risk-taking can be seen as
age-appropriate, the life-endangering risk of NA could
be related to feelings of injustice and lack of control in
an extremely strict and controlled lifestyle (Grinyer,
2009; Windebank & Spinetta, 2008). It could be argued
that this risk-taking is similar to, or a form of self-harm,
due to feelings of lack of control or in an attempt to
seek attention. By identifying TYAs who demonstrate
negative health beliefs or struggle emotionally with
their condition, it may be possible to predict those
TYAs who require additional support.
Model of Adherence
To address NA in TYAs, it is useful to consider the caus-
ative factors of NA, to help recognize those most at risk.
Figure 1 shows Ruddy et al.’s (2009) bio-psychosocial
model of adherence, which highlights the complexity of
the phenomenon of adherence. This model is of interest
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as the themes identified in the appraisal can be fit into
some of the different aspects of the model. However,
the most obvious criticism of this model when applied
to TYAs with cancer is that the role of the parents is
not recognized but the literature identifies that this is an
important factor in influencing adherence in TYAs
(Kennard et al., 2004; Kondryn et al., 2011; Windebank
& Spinetta, 2008).
Implications for Practice
With the factors affecting adherence in mind, Ruddy
et al’s. (2009) “model of adherence and persistence” has
been adapted to present what could be argued to be a
more appropriate theory of adherence for TYAs
(Figure 2). Building on the existing theory and the
themes that arose from the appraisal, this model was
refined using the recommendations/findings from the
appraisal to cover all aspects found to affect adherence.
When using this four-quadrant approach the personal
and external factors, along with treatment factors and
interactions with the system should all be considered
when addressing adherence.
This model may be useful if implemented into current
practice and education to give healthcare professionals an
insight into the complexity of the adherence phenomenon.
The use of this model could support professionals in rec-
ognizing which TYAs may be at great risk of NA.
Equally, if NA is identified, the model could also give
possible factors that could be affecting adherence for
the TYAs, which may give guidance for areas for future
support. Through “accurately assessing/identifying the
treatment challenges faced by TYAs cancer patients,”
healthcare professionals can “facilitate in the elucidation
of risk factors and mechanisms underlying patient non
adherence” (Kondryn et al., 2009, p. 1330).
Limitations and Bias
It has become apparent that there is a lack of contempo-
rary, well-designed research in this subject area where
there is little primary data. This review has suggested
some possible causations for NA in TYAs, but it has
Figure 1. Model of adherence and persistence.
200 Journal of Pediatric Oncology Nursing 38(3)
become apparent that there needs to be some high-quality
research carried out in this area to find ways to help
improve adherence. There are several factors that would
be interesting to be explored further, for example if
there is a difference between genders and adherence in
TYAs. This would also be particularly relevant in relation
to peer support. Due to a rise in technology and commu-
nication being very social media led, the development of
an app could potentially be beneficial in addressing
adherence.
Due to the small-scale nature of the appraisal only pub-
lished peer-reviewed journals focussing on adherence
were analyzed. The findings not only inform what is
already known and how it varies from different studies
but also what is not known about this subject area
(Hemingway & Brereton, 2009; Nicoll & Beyea, 1999).
Due to the lack of available literature, only one study
included in the literature review has been published in
the last 5 years. This may cause limitations to the findings
as there is a risk that the results of some studies may no
longer be relevant. This further supports the need for
further research in this area.
Conclusion
The appraisal highlighted both the complexities and diffi-
culties in measuring adherence, the key factors affecting
adherence, and implications for practice. Good
Figure 2. Model of adherence for teenagers and young adults (TYAs) with cancer.
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communication and relationships are crucial between all
parties involved in TYAs’ care including the patients,
professionals, parents, and peers. An adapted four-
quadrant model has been presented to show the complex-
ity and overlapping factors that affect adherence. It is
proposed that this model can act as a useful tool for
healthcare professionals caring for TYAs with cancer,
as it can serve as a possible indicator for those TYAs
who may be likely to become NA, as well as offering
some potential causative factors for TYAs who are
already NA. It is clear that further research needs to be
carried out in this area to find ways to improve adherence,
which in turn would increase overall survival.
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